Advertisement

Related Videos

Varsha Gandhi, PhD, on Ibrutinib

Kelvin Chan, MD, FRCPC, MSc, PhD, on Opportunities to Optimize Cancer Drug Policies: The Canadian Perspective

Robin Feldman, JD: Are Dubious Patents a Large or Small Issue?

Leonard B. Saltz, MD, on the Future of Interventional Pharmacoeconomics

Charles Schiffer, MD, on Cost-Effective Use of Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

Advertisement

Advertisement




Feb
10
Today In Oncology
HPV Testing During Cervical Cancer Screening Potential Convenient and Noninvasive Method
Guidelines Harmonize Pan-Tumor Pathologic Response to Neoadjuvant Therapy
Tissue-Free ctDNA and Outcomes in Patients With Colorectal Cancer Receiving FOLFOX-Based Adjuvant Therapy
Ultraprocessed Food Associated With Increased Mortality Risk in Cancer Survivors
A Paradigm Shift In Treating Adult AML?
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo